Retinitis Pigmentosa: Burden of Disease and Current Unmet Needs

Cross N, van Steen C, Zegaoui Y, Satherley A, Angelillo L

2022
Clinical Ophthalmology

View publication

Therapeutic Area

Back of the eye (BOTE)
Categories

Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

Affiliations

Market Access, Lightning Health, London, England, UK; Market Access HTA & HEOR, EMEA, Santen GmbH, Munich, Bavaria, Germany

Related Publications

Valosin-containing protein modulator KUS121 protects retinal neurons in a rat model of anterior ischemic optic neuropathy

Kikkawa C., Ikeda H.O., Hata M., Iwai S., Tsujikawa A.

Rapid and efficient generation of mature retinal organoids derived from human pluripotent stem cells via optimized pharmacological modulation of Sonic hedgehog, activin A, and retinoic acid signal transduction

Matsushita T.; Onishi A.; Matsuyama T.; Masuda T.; Ogino Y.; Kageyama M.; Takahashi M.; Uchiumi F.

Rotenone-Induced Optic Nerve Damage and Retinal Ganglion Cell Loss in Rats

Yamamoto Y.; Taniguchi T.; Shimazaki A.

View all Back of the eye (BOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022